Jack Dougherty Sold Jamaica Cures, LLC | Goodman & Nekvasil P.A., May Recover Losses
Goodman & Nekvasil, P.A is investigating the brokers who may have sold Jamaica Cures, LLC. Jack Dougherty sold Jamaica Cures, LLC.
Jamaica Cures, LLC Selling Away Investigation of Jack Dougherty
Jamaica Cures, LLC and the Risks of Private Placement Investments
JOHN ALOYSIUS DOUGHERTY, A.K.A, Jack Dougherty sold Jamaica Cures to a client who claims to have lost all of the investment principle. Dougherty was a registered representative of LPL FINANCIAL LLC and was terminated by his employer for selling Jamaica Cures, LLC, away from his member firm. Jack Dougherty was subsequently barred by FINRA from selling securities.
Many investors are not fully aware of the problems and risks associated with high risk, private placements when they purchase them.
Investments are often riskier and more complicated than traditional investments. These funds are only suitable for high net worth, sophisticated investors. These investments must also be approved by broker dealers before their registered representatives can sell the product to their customers.
Liquidity Issues and High Sales Commissions
REG D private placements like Jamaica Cures, LLC can face several liquidity issues due to their unique characteristics and structure.
Another problem often associated with private placements is the high sales commissions brokers typically earn for selling them. Brokers have an obligation to make investment recommendations that are consistent with their clients risk tolerance, net worth, investment objectives and experience in the market.
Unfortunately, in many cases, the high sales commission may influence unsuitable investment recommendations. JOHN ALOYSIUS DOUGHERTY, , a formerly registered broker, is accused of selling Jamaica Cures, LLC to a former client. Dougherty was subsequently fired and barred from selling securities.
Broker Due Diligence
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so may be held responsible for any losses in a FINRA arbitration claim.
If you believe that your investments in Jamaica Cures, LLC may have been unsuitable or otherwise improper for you, we would like to discuss the possibility of your retaining our firm to represent you in an arbitration action.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. If we don’t recover money for you, we charge no attorney’s fee.
Goodman & Nekvasil, P.A. has recovered more than $400 million on behalf of victimized investors. If you lost money on investments in unsuitable investments and would like your case evaluated by a securities attorney, please contact us.